MVP vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

MVP NAN
Technical
37
49
Catalyst
54
53
Sentiment
50
50
Fundamental
95
94
Momentum
49
41
Risk Gate
50
40

Key Metrics

MVP Metric NAN
$45.6MMarket Cap$965.5M
136KAvg Volume (20d)440K
N/AShort Interest+6.9%
$0.76552-Week High$4.770
$0.36552-Week Low$2.960
+0.0%Daily Change-0.3%
$0.405Reference Price$3.220
-0.8%ROE+10.1%
-1.1%Profit Margin+9.9%

Active Signals

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare MVP and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MVP vs NOX →MVP vs NTI →MVP vs PAR →MVP vs PIQ →MVP vs SPL →
MVP Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).